Wellington Management Group’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-70,418
Closed -$1.5M 2320
2021
Q4
$1.5M Sell
70,418
-622
-0.9% -$15.8K ﹤0.01% 1731
2021
Q3
$1.99M Sell
71,040
-678,578
-91% -$20.4M ﹤0.01% 1687
2021
Q2
$22.2M Sell
749,618
-164,821
-18% -$5.15M ﹤0.01% 1070
2021
Q1
$29.2M Sell
914,439
-185,107
-17% -$6.23M 0.01% 967
2020
Q4
$39.5M Buy
1,099,546
+32,464
+3% +$1.22M 0.01% 839
2020
Q3
$40.5M Sell
1,067,082
-36,898
-3% -$1.33M 0.01% 752
2020
Q2
$38.6M Sell
1,103,980
-329,111
-23% -$11.7M 0.01% 764
2020
Q1
$49.4M Sell
1,433,091
-41,958
-3% -$1.46M 0.01% 644
2019
Q4
$49M Sell
1,475,049
-211,447
-13% -$6.32M 0.01% 753
2019
Q3
$42.8M Sell
1,686,496
-79,168
-4% -$1.79M 0.01% 761
2019
Q2
$38.1M Buy
1,765,664
+12,710
+0.7% +$257K 0.01% 835
2019
Q1
$29.8M Sell
1,752,954
-52,561
-3% -$788K 0.01% 898
2018
Q4
$21M Sell
1,805,515
-104,468
-5% -$1.37M 0.01% 985
2018
Q3
$31.6M Buy
1,909,983
+16,362
+0.9% +$247K 0.01% 945
2018
Q2
$24M Sell
1,893,621
-45,375
-2% -$689K 0.01% 1031
2018
Q1
$29.1M Buy
1,938,996
+345,321
+22% +$5.36M 0.01% 941
2017
Q4
$21.7M Buy
1,593,675
+20,039
+1% +$315K ﹤0.01% 1045
2017
Q3
$30.2M Buy
+1,573,636
New +$29.6M 0.01% 919

Other funds holding ZEAL

Wellington Management Group's ZEAL Position: Q1 2022 in Review

Wellington Management Group sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q1 2022, closing a stake of 70,418 shares — an estimated $1.5M sold.

Wellington Management Group first reported a position in ZEAL in Q3 2017 and held it in 18 quarters. The position peaked at $49.4M in Q1 2020. 10 funds tracked by Wall St. Rank hold ZEAL as of Q1 2022.

  • Wellington Management Group reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • Wellington Management Group sold 70,418 Zealand Pharma A/S American Depositary Shares shares in Q1 2022, an estimated $1.5M.
  • Wellington Management Group first reported a position in Zealand Pharma A/S American Depositary Shares in Q3 2017 and held it in 18 quarters.
  • Wellington Management Group's Zealand Pharma A/S American Depositary Shares position peaked at $49.4M in Q1 2020.
  • 10 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q1 2022.

Based on Wellington Management Group's 13F filing for Q1 2022, filed 16 May 2022.